Loading Results
We have updated our Online Services Terms of Use and Privacy Policy. See our Cookies Notice for information concerning our use of cookies and similar technologies. By using this website or clicking “I ACCEPT”, you consent to our Online Services Terms of Use.

Schedule an appointment today

Center for Developmental Therapeutics Identifies Novel Drugs for Refractory Cancer

Center for Developmental TherapeuticsThe Center for Developmental Therapeutics at University Hospitals Rainbow Babies & Children’s Hospital’s Angie Fowler Adolescent & Young Adult Cancer Institute focuses on quickly translating scientific findings to identify safer, more effective drugs for children, adolescents and young adults with relapsed and refractory cancers. These cancers are the toughest to treat and have been resistant to previous, conventional treatments.

Novel Methods of Cancer Care

In most cases of relapsed or refractory cancers, there was never a cancer cure and treatment options have been exhausted. However, now doctors at UH Rainbow Babies & Children’s Hospital can provide cancer treatments that may work in a unique way, giving children new methods of care while keeping the family close to home.

Multifaceted Approach to Treating Cancer

Leaders at the Center for Developmental Therapeutics work alongside colleagues at University Hospitals Seidman Cancer Center, part of the National Cancer Institute-designated Case Comprehensive Cancer Center at Case Western Reserve University School of Medicine. This joint, multidisciplinary approach to cancer care provides access to both pediatric and adult clinical trials, offering young patients their very best chance for a cancer cure.

Trusted Partner For New Cancer Treatment

Through the Center for Developmental Therapeutics, UH Rainbow Babies & Children’s Hospital will serve as a trusted partner for referring physicians, patients and families seeking new cancer treatments for children and young adults for whom conventional treatments have failed, particularly when time is of the essence. As the only institution to provide access to investigational Phase I and Phase II clinical trials in northern Ohio, our cancer specialists will be available for consults with referring physicians within northern Ohio, as well as those in other regions of Ohio and surrounding states.